Agilent Technologies Inc Stock Price Prediction 2026, 2027, 2030, 2040, 2050
Agilent Technologies Inc. makes laboratory equipment, testing tools, software, and other technology. Its products are used by scientists, hospitals, pharmaceutical companies, universities, and research laboratories. The company makes tools that help test medicines, chemicals, DNA, biological samples, and other materials. It became an independent company after separating from Hewlett-Packard in 1999 and is based in Santa Clara, California. So this company is very useful for making laboratory tools that help scientists test and study different materials and samples.
What is Agilent Technologies Inc NYSE: A?
Agilent Technologies, Inc. was established in 1999 in Santa Clara, California, and it is owned by its shareholders because it is a public company. It makes laboratory machines, testing tools, software, and other products used by scientists, hospitals, medicine companies, universities, and research labs. Its products help people test medicines, chemicals, DNA, blood samples, and other materials. The company also makes advanced tools that help scientists study and measure different substances. It provides products for areas such as healthcare, life sciences, food testing, environmental testing, and chemical research.
Agilent Technologies Stock Price
Agilent Technologies Stock Price Prediction 2026
Agilent was created in 1999 when HP separated some of its businesses and formed a new company. At that time, it worked in areas such as testing equipment, chemical testing, healthcare, and semiconductor products. The company became fully independent in June 2000. Over time, it changed its business and started focusing more on laboratory technology, life sciences, healthcare, and chemical testing. In 2026, its stock price would be $221, as per stock market analysts.
According to stock market analysts, its stock price would be between $108 to $221 in 2026.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2026 | $108 | $221 |
| Month | Minimum Price ($) | Maximum Price ($) |
| January | $129 | $150 |
| February | $114 | $137 |
| March | $109 | $120 |
| April | $110 | $124 |
| May | $108 | $140 |
| June | $123 | $140 |
| July | $125 | $142 |
| August | $136 | $163 |
| September | $141 | $183 |
| October | $145 | $198 |
| November | $140 | $215 |
| December | $168 | $221 |
Agilent Technologies Stock Price Target 2027
It makes laboratory equipment, software, testing tools, and other products that help scientists and laboratories test different samples. Its products can be used to test medicines, chemicals, food, water, biological samples, and other materials. The company does more than just sell laboratory machines. It also provides software, equipment maintenance, technical support, and other services. Its products can be used at different stages of laboratory work, including research, testing, and quality checks. In 2027, its stock price would be $332, as per stock market analysts.
According to stock market analysts, its stock price would be between $215 to $332 in 2027.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2027 | $215 | $332 |
| Month | Minimum Price ($) | Maximum Price ($) |
| January | $215 | $250 |
| February | $219 | $267 |
| March | $225 | $275 |
| April | $227 | $282 |
| May | $232 | $288 |
| June | $237 | $293 |
| July | $241 | $298 |
| August | $244 | $311 |
| September | $252 | $315 |
| October | $257 | $319 |
| November | $262 | $322 |
| December | $270 | $332 |
Stock Price Prediction 2028
It has a major business in life sciences and diagnostics. This business serves pharmaceutical companies, biotechnology companies, hospitals, and medical laboratories. It provides technology that can be used for scientific research, medicine development, and medical testing. Its products include equipment for liquid chromatography, mass spectrometry, genetic testing, cell analysis, and pathology. These tools help scientists study biological samples and understand diseases and medicines. In 2028, its stock price would be $421, as per stock market analysts.
According to stock market analysts, its stock price would be between $318 to $421 in 2028.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2028 | $318 | $421 |
Stock Price Prediction 2029
Drug companies need accurate laboratory equipment to research, develop, make, and test medicines. This company provides machines, software, laboratory supplies, and services that support these activities. Its products can help drug companies check the quality and purity of medicines and test the materials used to make them. It also provides technical support and laboratory services to its customers. Its products can be used from the early research stage to medicine production and final testing. In 2029, its stock price would be $507, as per stock market analysts.
According to stock market analysts, its stock price would be between $415 to $507 in 2029.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2029 | $415 | $507 |
Agilent Technologies Stock Price Prediction 2030
It also provides technology for the food industry and food safety testing. Food companies, laboratories, and government organisations need to test food to make sure it is safe. It provides laboratory equipment that can help find harmful chemicals, bacteria, and other unwanted substances in food. These tools help laboratories check food samples and measure different substances accurately. Food testing is important because some harmful substances can be present in very small amounts and may not be easy to find. In 2030, its stock price would be $642, as per stock market analysts.
According to stock market analysts, its stock price would be between $490 to $642 in 2030.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2030 | $490 | $642 |
| Month | Minimum Price ($) | Maximum Price ($) |
| January | $490 | $545 |
| February | $497 | $559 |
| March | $511 | $568 |
| April | $517 | $578 |
| May | $524 | $586 |
| June | $532 | $598 |
| July | $540 | $604 |
| August | $544 | $611 |
| September | $547 | $615 |
| October | $552 | $624 |
| November | $562 | $635 |
| December | $571 | $642 |
Stock Price Prediction 2040
It also works in environmental testing. Laboratories use its equipment to test samples from water, soil, and other parts of the environment. It provides tools that can help find pesticides, chemicals, medicine residues, metals, and other unwanted substances. These substances may be present in very small amounts, so laboratories need accurate equipment to detect them. Its technology helps laboratories measure these substances and understand the condition of environmental samples. In 2040, its stock price would be $1415, as per stock market analysts.
According to stock market analysts, its stock price would be between $1260 to $1415 in 2040.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2040 | $1260 | $1415 |
| Month | Minimum Price ($) | Maximum Price ($) |
| January | $1260 | $1290 |
| February | $1265 | $1311 |
| March | $1272 | $1318 |
| April | $1280 | $1327 |
| May | $1282 | $1342 |
| June | $1285 | $1353 |
| July | $1283 | $1359 |
| August | $1289 | $1362 |
| September | $1295 | $1377 |
| October | $1315 | $1386 |
| November | $1335 | $1400 |
| December | $1355 | $1415 |
Stock Price Prediction 2050
Its technology is also used in forensic science and law enforcement. Forensic laboratories use special equipment to study evidence and identify different substances. It provides testing tools that help experts examine samples and get accurate results. These results can be useful during investigations and legal cases. Its equipment is also used for sports anti-doping tests, where laboratories check samples for banned substances. In 2050, its stock price would be $2163, as per stock market analysts.
According to stock market analysts, its stock price would be between $2043 to $2163 in 2050.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2050 | $2043 | $2163 |
| Month | Minimum Price ($) | Maximum Price ($) |
| January | $2043 | $2100 |
| February | $2050 | $2119 |
| March | $2055 | $2128 |
| April | $2057 | $2142 |
| May | $2065 | $2153 |
| June | $2069 | $2162 |
| July | $2075 | $2175 |
| August | $2082 | $2185 |
| September | $2089 | $2198 |
| October | $2098 | $2207 |
| November | $2115 | $2218 |
| December | $2145 | $2230 |
Should I buy Agilent Technologies stock?
| Year | Minimum Price ($) | Maximum Price ($) |
| 2026 | $108 | $221 |
| 2027 | $215 | $332 |
| 2028 | $318 | $421 |
| 2029 | $415 | $507 |
| 2030 | $490 | $642 |
| 2040 | $1260 | $1415 |
| 2050 | $2043 | $2163 |
It has a strong business and sells laboratory equipment, testing tools, software, and services. It works with important industries such as healthcare, pharmaceuticals, life sciences, food testing, and environmental testing. The company is growing its business and continues to develop new products and services. But the stock price is already high, so investors should check the valuation carefully before buying. So, it could be suitable for investors who want to invest in the laboratory and healthcare technology sector for the long term.
Agilent Technologies Financials
| Financial Year | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 |
| Total Revenue | 1.68 | 1.66 | 1.73 | 1.86 | 1.79 | 1.83 | 1.87 |
| Gross Profit | 0.89 | 0.86 | 0.91 | 0.96 | 0.94 | 1 | 1.04 |
| Net Income | 0.31 | 0.21 | 0.33 | 0.43 | 0.30 | 0.33 | 0.36 |
| Net Profit Margin | 18.91% | 12.88% | 19.33% | 23.32% | 16.96% | 18.47% | 19.27% |
Key Metrics
| PE TTM | PB | EPS TTM | PEG Ratio | Profit Margin | Dividend Yield |
| 31.94 | 5.99 | $5.07 | 1.29 | 19.53% | 0.65% |
Peers & Comparison
| Stock | PE TTM | PB | PEG Ratio |
| Agilent Technologies Inc | 31.94 | 5.99 | 1.29 |
| Thermo Fisher Scientific Inc | 35.47 | 4.57 | 1.94 |
| IQVIA Holdings Inc | 33.41 | 7.10 | 0.96 |
Is Agilent Technologies stock good to buy? (bull case & bear case)
Bull Case:
- It made $1.88 billion in revenue in Q3 FY2026, up 8.1% from the same quarter last year.
- Its net income was $362 million, compared with $336 million in Q3 FY2025. This means the company also earned more profit.
- Its EPS increased to $1.28 from $1.18 a year earlier, showing improvement in earnings per share.
- The Life Sciences and Diagnostics Markets Group made $746 million in revenue, up 11% year over year.
- Applied Markets Group made $346 million in revenue, up 7%, with an operating margin of 24.9%.
- It expects FY2026 revenue of $7.49 billion to $7.51 billion, with core growth of around 5.8% to 6.0%.
- For Q4 FY2026, it expects revenue of $1.98 billion to $2.00 billion and non-GAAP EPS of $1.71 to $1.74.
Bear Case:
- Revenue growth is still moderate. Q3 FY2026 revenue grew 8.1%, while core revenue grew 7.3%.
- Its non-GAAP operating margin was 28.3% in Q3. However, tariff refunds added about 110 basis points to this margin.
- Without the tariff refund benefit, the non-GAAP operating margin would have been around 27.2%.
- It expects Q4 FY2026 revenue of $1.98 billion to $2.00 billion, with core growth of 5.2% to 6.2%.
Conclusion
It has a strong business in laboratory equipment, testing tools, software, and scientific products. It serves healthcare, pharmaceutical, life sciences, food, and environmental industries. The company is growing its sales and profits, but some markets are still weak, and growth is not very fast. Its stock price is also quite high, so investors should check the valuation before buying. It could be suitable for long-term investors who want exposure to the laboratory and healthcare technology sector, but future returns will depend on the company’s growth and stock price.
